Table 4. Associations of Leptin/Adiponectin Ratio with Incident Cardiovascular Disease in Inter99.
Model 1 (n = 5,854) | Model 2 (n = 5,800) | Model 3 (n = 5,763) | ||||
---|---|---|---|---|---|---|
Events | HR (95% CI) | Events | HR (95% CI) | Events | HR (95% CI) | |
Combined events | 464 | 1.20 (1.09–1.32)* | 457 | 1.02 (0.91–1.13) | 453 | 1.00 (0.88–1.15) |
IHD | 303 | 1.26 (1.13–1.42)* | 299 | 1.00 (0.89–1.15) | 297 | 1.00 (0.86–1.19) |
Stroke | 184 | 1.12 (0.97–1.30) | 181 | 1.07 (0.90–1.26) | 179 | 1.08 (0.88–1.33) |
Data are presented as Hazard Ratio per one standard deviation increase in log transformed Leptin/Adiponectin ratio. Model 1: Adjusted for sex, age and intervention group. Model 2: Model 1 + total cholesterol, HDL-cholesterol, smoking status, systolic blood pressure, treatment for hypertension and baseline diabetes. Model 3: Model 2 + BMI, HOMA-IR, eGFR and CRP.
*P <0.001